Cognition Therapeutics Inc

NASDAQ:CGTX   3:59:51 PM EDT
8.45
+0.08 (+0.96%)
Earnings Announcements

Cognition Therapeutics Reports Q3 Loss Per Share of $8.12

Published: 11/18/2021 13:32 GMT
Cognition Therapeutics Inc (CGTX) - Cognition Therapeutics Reports Third Quarter Financial Results and Company Highlights.
Q3 Loss per Share $8.12.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.